PubRank

J N Barker

Author PubWeight™ 74.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Psoriasis in practice. Lancet 1991 2.78
2 Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997 2.43
3 Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 1991 2.24
4 Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study. Br J Dermatol 2013 2.10
5 Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant 2013 2.04
6 A non-HLA gene within the MHC in psoriasis. Lancet 1999 1.67
7 Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001 1.63
8 Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol 2014 1.57
9 Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 1991 1.57
10 A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis. Clin Exp Dermatol 2000 1.46
11 Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet 2007 1.44
12 Pulmonary capillary leak syndrome complicating generalized pustular psoriasis: possible role of cytokines. Br J Dermatol 1991 1.41
13 Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol 1999 1.32
14 The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease--1990 update. J Invest Dermatol 1990 1.29
15 Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet 2001 1.23
16 Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant 2009 1.21
17 Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (rhus dermatitis). Br J Dermatol 1991 1.14
18 Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes. Genes Immun 2009 1.12
19 The development of excess numbers of melanocytic naevi in an immunosuppressed identical twin. Clin Exp Dermatol 1991 1.12
20 Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 1993 1.10
21 Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis. Br J Dermatol 1997 1.08
22 Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 1995 1.02
23 Effect of in vivo interleukin-1 on adhesion molecule expression in normal human skin. J Invest Dermatol 1992 0.99
24 Atypical pigmented lesions following extensive PUVA therapy. Clin Exp Dermatol 2000 0.95
25 Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation. Bone Marrow Transplant 2011 0.93
26 Langerhans' cell expression of the selectin ligand, sialyl Lewis x. Immunology 1994 0.92
27 Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: in situ expression of beta 2-integrins. J Am Acad Dermatol 1992 0.92
28 Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin. Br J Dermatol 1998 0.91
29 Eruptive dysplastic naevi following renal transplantation. Clin Exp Dermatol 1988 0.91
30 Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol 2001 0.90
31 Contrasting patterns of streptococcal superantigen-induced T-cell proliferation in guttate vs. chronic plaque psoriasis. Br J Dermatol 2001 0.88
32 Fetal and neonatal cerebral blood flow. Am J Physiol 1966 0.88
33 Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis. J Med Genet 2004 0.88
34 Keratinocyte HLA-DR expression: the relationship to dermal lymphocytic infiltration. Clin Exp Dermatol 1987 0.86
35 HUT 78 T cells bind to noncytokine-stimulated keratinocytes using a non-CD18-dependent adhesion pathway. Am J Pathol 1992 0.85
36 Early migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells into evolving psoriatic plaques. Exp Dermatol 2001 0.85
37 Vascular proliferation and angiogenic factors in psoriasis. Clin Exp Dermatol 1995 0.85
38 Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma. J Am Acad Dermatol 1993 0.84
39 Detection of circulating adhesion molecules in erythrodermic skin disease. J Am Acad Dermatol 1995 0.84
40 Expression of selectin ligands by cutaneous squamous cell carcinoma. Am J Pathol 1993 0.83
41 Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1993 0.83
42 Epidermal class II human lymphocyte antigen expression in atopic dermatitis: a comparison with experimental allergic contact dermatitis. J Am Acad Dermatol 1987 0.83
43 The tissue distribution of factor XIIIa positive cells. Histopathology 1993 0.82
44 Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis. Immunogenetics 2000 0.82
45 Adhesion molecules in allergic inflammation. Am Rev Respir Dis 1993 0.82
46 Generalized pustular psoriasis or drug-induced toxic pustuloderma? The use of patch testing. Clin Exp Dermatol 2000 0.81
47 Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis. Br J Dermatol 1999 0.81
48 A case of chromoblastomycosis responding to treatment with itraconazole. Br J Dermatol 1993 0.81
49 Ultraviolet B induced suppression of induction of contact sensitivity in human skin is not associated with tumour necrosis factor-alpha-308 or interleukin-10 genetic polymorphisms. Br J Dermatol 1998 0.81
50 Circulating vascular permeability factor/vascular endothelial growth factor in erythroderma. Lancet 1996 0.81
51 Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours. Br J Dermatol 1996 0.80
52 Susceptibility to effects of UVB irradiation on induction of contact sensitivity, relevance of number and function of Langerhans cells and epidermal macrophages. Photochem Photobiol 1998 0.80
53 Increased T-cell receptor vbeta2 chain expression in skin homing lymphocytes in psoriasis. Br J Dermatol 1999 0.80
54 Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial. Bone Marrow Transplant 2007 0.80
55 NAP-1/IL-8 immunoreactivity in normal and psoriatic skin. J Invest Dermatol 1991 0.79
56 Adhesion molecule expression in polymorphic light eruption. J Invest Dermatol 1992 0.79
57 E-selectin binds to squamous cell carcinoma and keratinocyte cell lines. J Invest Dermatol 1996 0.79
58 Successful unrelated donor cord blood transplantation for adult sickle cell disease and Hodgkin lymphoma. Bone Marrow Transplant 2009 0.79
59 Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland. Br J Dermatol 2012 0.78
60 Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects. Br J Dermatol 1998 0.78
61 Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis. Clin Exp Dermatol 2001 0.78
62 Development behaviors: delayed appearance in monkeys asphyxiated at birth. Science 1971 0.77
63 Platelet activating factor-induced clinical and histopathologic responses in atopic skin and their modification by the platelet activating factor antagonist BN52063. J Am Acad Dermatol 1990 0.77
64 Local blood flow and local metabolic activity in aged rat brain. Eur Neurol 1972 0.77
65 Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries. Br J Dermatol 2001 0.77
66 An association between psoriasis and hereditary multiple exostoses. A clue for the mapping of a psoriasis susceptibility gene? Br J Dermatol 1994 0.76
67 Developmental behaviors: delayed appearance in monkeys asphyxiated at birth. Science 1971 0.76
68 CD44 variant expression in cutaneous T-cell lymphoma. J Cutan Pathol 1997 0.76
69 Cell trafficking and role of adhesion molecules in psoriasis. Clin Dermatol 1995 0.75
70 Keratinocyte expression of CD36 antigen in benign and malignant epidermal cell-derived tumours. J Cutan Pathol 1991 0.75
71 Expression of the myelomonocytic antigens L1 and CD36 in human epidermis. Br J Dermatol 1990 0.75
72 Evaluation of lingual artery hemodynamics in stroke patients using Doppler ultrasound. Oral Surg Oral Med Oral Pathol 1981 0.75
73 Optimising the use of tazarotene in clinical practice: consensus statement from the European advisory panel for tazarotene (Zorac TM). Dermatology 1999 0.75
74 Long-wave UVA offers partial protection against UVB-induced immune suppression in human skin. APMIS 2000 0.75
75 Contrasting effects of ultraviolet-A and ultraviolet-B exposure on induction of contact sensitivity in human skin. Clin Exp Immunol 1997 0.75
76 Pathophysiological aspects of psoriasis. Eur J Med 1992 0.75
77 Ramipril-associated lichen planus pemphigoides. Br J Dermatol 1997 0.75
78 Hamartoma moniliformis--a case report. Clin Exp Dermatol 1988 0.75
79 Interferon-gamma activates co-ordinate transcription of HLA-DR, DQ, and DP genes in cultured keratinocytes and requires de novo protein synthesis. J Invest Dermatol 1990 0.75
80 Understanding cerebrovascular function. Contributions of space techniques. N Y State J Med 1973 0.75
81 Diffuse plane xanthomatosis and acquired palmoplantar keratoderma in association with myeloma. Br J Dermatol 1995 0.75
82 Bullous pemphigoid developing during systemic therapy with chloroquine. Clin Exp Dermatol 1999 0.75
83 In vivo UVA-1 and UVB irradiation differentially perturbs the antigen-presenting function of human epidermal Langerhans cells. J Invest Dermatol 1999 0.75
84 Generalized endemic Kaposi's sarcoma. Clin Exp Dermatol 1995 0.75
85 Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis. Br J Dermatol 2014 0.75
86 Truncal hypopigmented macules and facial hyperpigmented papules. Arch Dermatol 2000 0.75
87 Exclusion of interleukin-1 receptor antagonist as a primary disease determinant for psoriasis. J Invest Dermatol 1995 0.75
88 Antigenic profile of human acrosyringium. Br J Dermatol 1991 0.75